One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-153575
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 10 |
Affiliation: Mayo Clinic, Winneshiek Medical Center, Memorial Sloan Kettering Cancer Center, Colorado Blood Cancer Institute, Sarah Cannon, Washington University in St. Louis, University of California, San Francisco, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Icahn School of Medicine at Mount Sinai, Levine Cancer Institute, Massachusetts General Hospital, C4 Therapeutics (United States), Emory UniversityA Phase 1 Study of CFT7455, a Novel Degrader of IKZF1/3, in Multiple Myeloma and Non-Hodgkin Lymphoma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
